CC, B., AP, W., YC, C., S, L., HJ, M., WH, L., . . . YX, L. (2016). Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment. Dove Medical Press.
Cita Chicago Style (17a ed.)CC, Bi, Wang AP, Chu YC, Liu S, Mu HJ, Liu WH, Wu ZM, Sun KX, y Li YX. Intranasal Delivery of Rotigotine to the Brain with Lactoferrin-modified PEG-PLGA Nanoparticles for Parkinson’s Disease Treatment. Dove Medical Press, 2016.
Cita MLA (8a ed.)CC, Bi, et al. Intranasal Delivery of Rotigotine to the Brain with Lactoferrin-modified PEG-PLGA Nanoparticles for Parkinson’s Disease Treatment. Dove Medical Press, 2016.
Precaución: Estas citas no son 100% exactas.